Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. September 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the Rodman & Renshaw 18th Annual Global Investment Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
10. August 2016 07:00 ET | Quelle: Foamix, Ltd.

Foamix Reports Second Quarter 2016 Financial Results and Provides Business Update

REHOVOT, Israel, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company...
25. Juli 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, August 10

REHOVOT, Israel and BRIDGEWATER, N.J., July 25, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
01. Juni 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present at the BIO International Convention

REHOVOT, Israel and BRIDGEWATER, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
31. Mai 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting

REHOVOT, Israel and BRIDGEWATER, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
26. Mai 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the Jefferies 2016 Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., May 26, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
16. Mai 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix Names Dr. Stanley Hirsch as Chairman, and Dr. Dalia Megiddo as a Member of the Board of Foamix Pharmaceuticals

REHOVOT, Israel and BRIDGEWATER, N.J., May 16, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
10. Mai 2016 06:00 ET | Quelle: Foamix, Ltd.

Foamix Reports First Quarter 2016 Financial Results and Provides Business Update

REHOVOT, Israel, May 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing...
09. Mai 2016 07:00 ET | Quelle: Foamix, Ltd.

Foamix Announces Dosing of First Patient in Phase 3 Acne Studies for Minocycline Foam FMX101

REHOVOT, Israel, and BRIDGEWATER, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
03. Mai 2016 08:00 ET | Quelle: Foamix, Ltd.

Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular Rosacea

REHOVOT, Israel and BRIDGEWATER, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...

Vorherige Seite